Please wait while we load the requested 10-Q report or click the link below:
https://last10k.com/sec-filings/report/1622996/000164033418000321/acbm_10q.htm
SEC Filings
ACBM Annual Reports
ACBM Quarterly Reports
10-Q Quarterly Report November 2022
10-Q Quarterly Report August 2022
10-Q Quarterly Report May 2022
10-Q Quarterly Report November 2021
10-Q Quarterly Report August 2021
10-Q Quarterly Report May 2021
10-Q Quarterly Report November 2020
10-Q Quarterly Report August 2020
10-Q Quarterly Report May 2020
10-Q Quarterly Report August 2019
10-Q Quarterly Report November 2022
10-Q Quarterly Report August 2022
10-Q Quarterly Report May 2022
10-Q Quarterly Report November 2021
10-Q Quarterly Report August 2021
10-Q Quarterly Report May 2021
10-Q Quarterly Report November 2020
10-Q Quarterly Report August 2020
10-Q Quarterly Report May 2020
10-Q Quarterly Report August 2019
Last10K.com | 10-Q Quarterly Report Wed Feb 14 2018
Document And Entity Information - shares | 3 Months Ended | |
|---|---|---|
Dec. 31, 2017 | Feb. 14, 2018 | |
| Document And Entity Information [Abstract] | ||
| Entity Registrant Name | ACRO BIOMEDICAL CO., LTD. | |
| Entity Central Index Key | 0001622996 | |
| Trading Symbol | acbm | |
| Current Fiscal Year End Date | --09-30 | |
| Entity Filer Category | Smaller Reporting Company | |
| Entity Common Stock, Shares Outstanding | 47,660,000 | |
| Document Type | 10-Q | |
| Document Period End Date | Dec. 31, 2017 | |
| Amendment Flag | false | |
| Document Fiscal Year Focus | 2018 | |
| Document Fiscal Period Focus | Q1 |
View differences made from one quarter to another to evaluate Acro Biomedical Co., Ltd.'s financial trajectory
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed , added and changed by Acro Biomedical Co., Ltd..
Assess how Acro Biomedical Co., Ltd.'s management team is paid from their Annual Proxy
Acro Biomedical Co., Ltd.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2018 10-K Annual Report includes:
- Voting Procedures
- Board Members
- Executive Team
- Salaries, Bonuses, Perks
- Peers / Competitors
SEC Filing Tools
Financial Statements, Disclosures and Schedules
Inside this 10-Q Quarterly Report
Document And Entity Information
Balance Sheets
Balance Sheets (parentheticals)
Statements Of Cash Flows (unaudited)
Statements Of Operations (unaudited)
Commitments And Contingencies
Commitments And Contingencies (detail Textuals)
Going Concern
Going Concern (detail Textuals)
Income Taxes
Income Taxes (detail Textuals)
Income Taxes (details) - Summary Of Provision For Income Taxes
Income Taxes (tables)
Income Taxes - Summary Of Componenets Of Net Deferrd Tax Assets (details 1)
Organization And Description Of Business
Organization And Description Of Business (detail Textuals)
Related Party Transactions
Related Party Transactions (detail Textuals)
Summary Of Significant Accounting Policies
Summary Of Significant Accounting Policies (detail Textuals 1)
Summary Of Significant Accounting Policies (detail Textuals)
Summary Of Significant Accounting Policies (policies)
Material Contracts, Statements, Certifications & more
Acro Biomedical Co., Ltd. provided additional information to their SEC Filing as exhibits
Ticker: ACBM
CIK: 1622996
Form Type: 10-Q Quarterly Report
Accession Number: 0001640334-18-000321
Submitted to the SEC: Wed Feb 14 2018 5:17:39 PM EST
Accepted by the SEC: Wed Feb 14 2018
Period: Sunday, December 31, 2017
Industry: Amusement And Recreation Services
External Resources:
Stock Quote
Social Media
Bookmark the Permalink: https://last10k.com/sec-filings/acbm/0001640334-18-000321.htm
SEC Filing Exhibit
PDF Download
Loading SEC Filing Exhibit...
Excel DownloadLoading SEC Filing Financial Summary...